Artículos por temáticas

What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study

Jeon N, Bortolato M.

PLoS One. 2020 Jan 7;15(1):e0227128. doi: 10.1371/journal.pone.0227128. eCollection 2020.

Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease

de Faria SM, de Morais Fabrício D, Tumas V, Castro PC, Ponti MA, Hallak JE, Zuardi AW, Crippa JAS, Chagas MHN.

J Psychopharmacol. 2020 Feb;34(2):189-196. doi: 10.1177/0269881119895536. Epub 2020 Jan 7.

Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra

Zhang Y, Meng X, Jiao Z, Liu Y, Zhang X, Qu S.

ACS Chem Neurosci. 2020 Feb 5;11(3):406-417. doi: 10.1021/acschemneuro.9b00609. Epub 2020 Jan 21.

Topological changes in white matter connectivity network in patients with Parkinson's disease and depression

Hu X, Qian L, Zhang Y, Xu Y, Zheng L, Liu Y, Zhang X, Zhang Y, Liu W.

Brain Imaging Behav. 2020 Dec;14(6):2559-2568. doi: 10.1007/s11682-019-00208-2.

Parkinson's disease: proteinopathy or lipidopathy?

Fanning S, Selkoe D, Dettmer U.

NPJ Parkinsons Dis. 2020 Jan 3;6:3. doi: 10.1038/s41531-019-0103-7. eCollection 2020.

[Current Status and Future Prospects of Therapeutic Development of Parkinson's Disease]

Mochizuki H.

Brain Nerve. 2020 Jan;72(1):35-43. doi: 10.11477/mf.1416201476.

[Application of intracranial lead reconstruction in deep brain stimulation therapy in patients with Parkinson's disease].

Zheng X, Yu L, Wan X, Wang H, Yu T, He Q, Lin Z, Kang D.

Nan Fang Yi Ke Da Xue Xue Bao. 2019 Dec 30;39(12):1461-1468. doi: 10.12122/j.issn.1673-4254.2019.12.10. Chinese.

L-DOPA in Parkinson's Disease: Looking at the "False" Neurotransmitters and Their Meaning.

Chagraoui A, Boulain M, Juvin L, Anouar Y, Barrière G, Deurwaerdère P.

Int J Mol Sci. 2019 Dec 31;21(1). pii: E294. doi: 10.3390/ijms21010294. Review.

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson's Disease through Activating Mitophagy.

Lin MW, Lin CC, Chen YH, Yang HB, Hung SY.

Antioxidants (Basel). 2019 Dec 31;9(1). pii: E37. doi: 10.3390/antiox9010037.

A Multimodal Approach to the Quantification of Kinetic Tremor in Parkinson's Disease.

Szumilas M, Lewenstein K, Ślubowska E, Szlufik S, Koziorowski D.

Sensors (Basel). 2019 Dec 28;20(1). pii: E184. doi: 10.3390/s20010184.

In Vivo Mitochondrial Function in Idiopathic and Genetic Parkinson's Disease.

Dossi G, Squarcina L, Rango M.

Metabolites. 2019 Dec 28;10(1). pii: E19. doi: 10.3390/metabo10010019. Review.

Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson's disease

Ci YZ, Li H, You LH, Jin Y, Zhou R, Gao G, Hoi MPM, Wang C, Chang YZ, Yu P.

Neurochem Int. 2020 Mar;134:104657. doi: 10.1016/j.neuint.2019.104657. Epub 2020 Jan 2.

Designing Virtual Reality Assisted Psychotherapy for Anxiety in Older Adults Living with Parkinson's Disease: Integrating Literature for Scoping

Thangavelu K, Hayward JA, Pachana NA, Byrne GJ, Mitchell LK, Wallis GM, Au TR, Dissanayaka NN.

Clin Gerontol. 2020 Jan 6:1-17. doi: 10.1080/07317115.2019.1709597. Online ahead of print.

Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons

Ahfeldt T, Ordureau A, Bell C, Sarrafha L, Sun C, Piccinotti S, Grass T, Parfitt GM, Paulo JA, Yanagawa F, Uozumi T, Kiyota Y, Harper JW, Rubin LL.

Stem Cell Reports. 2020 Jan 14;14(1):75-90. doi: 10.1016/j.stemcr.2019.12.005. Epub 2020 Jan 2.

Dynamics of impulsive-compulsive behaviors in early Parkinson's disease: a prospective study

Marković V, Stanković I, Petrović I, Stojković T, Dragašević-Mišković N, Radovanović S, Svetel M, Stefanova E, Kostić V.

J Neurol. 2020 Apr;267(4):1127-1136. doi: 10.1007/s00415-019-09692-4. Epub 2020 Jan 4.